Subtype
Malignant Glioma
CI-CAN-00003164Explore in graph →
589 active trials3 approved drugs67 evidence items
- NCIt
- C4822
Loading cancer entity…
Subtype
CI-CAN-00003164Explore in graph →
Clinical trials
2,053 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (325)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05768087 | Escalated Dose Proton Therapy Within the Multimodality Treatment of Glioblastoma Patients | recruiting | N/A | 36 | University of AarhusOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT06381726 | Personalized Rendering of Motor System Functional Plasticity Potential to Improve Glioma Resection and Quality of Life | recruiting | N/A | 400 | University of MilanOTHER | 1 | Apr 24, 2024 | clinicaltrials |
| NCT06368934 |
| Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma |
| not yet recruiting |
| N/A |
| 326 |
| Huashan HospitalOTHER |
| 1 |
| Apr 16, 2024 |
| clinicaltrials |
| NCT03712293 | ExAblate Blood-Brain Barrier Disruption for Glioblastoma in Patients Undergoing Standard Chemotherapy | completed | N/A | 9 | InSightecINDUSTRY | 1 | Mar 5, 2024 | clinicaltrials |
| NCT06271421 | NanoTherm In Adjuvant Therapy of Glioblastoma Multiforme(ANCHIALE) | recruiting | N/A | 100 | Poznan University of Medical SciencesOTHER | 1 | Feb 26, 2024 | clinicaltrials |
| NCT04530006 | Acetyl-Amantadine as a Biomarker in Patients With Glioblastoma | unknown | N/A | 20 | CancerCare ManitobaOTHER | 1 | Feb 23, 2024 | clinicaltrials |
| NCT06241391 | Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas | unknown | N/A | 35 | All India Institute of Medical Sciences, BhubaneswarOTHER | 1 | Feb 8, 2024 | clinicaltrials |
| NCT06001281 | Predictive Value of Soluble CD146 in Glioblastoma Patients(MUCIGLIO-01) | recruiting | N/A | 55 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Feb 2, 2024 | clinicaltrials |
| NCT03616860 | Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption for Treatment of Glioma | completed | N/A | 14 | InSightecINDUSTRY | 1 | Jan 23, 2024 | clinicaltrials |
| NCT06196918 | Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients | unknown | N/A | 320 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Jan 9, 2024 | clinicaltrials |
| NCT03861299 | The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.(SAFE) | recruiting | N/A | 246 | Jasper GerritsenOTHER | 2 | Nov 21, 2023 | clinicaltrials |
| NCT04763031 | Recurrent GBM With Maximal Neurosurgical Removal and Treatment With IORT | terminated | N/A | 1 | Parkridge Medical CenterOTHER | 1 | Nov 9, 2023 | clinicaltrials |
| NCT03557372 | Mathematical Model-Adapted Radiation In Glioblastoma | completed | N/A | 14 | Dana-Farber Cancer InstituteOTHER | 1 | Oct 26, 2023 | clinicaltrials |
| NCT06093165 | RE-irradiation of Diffuse MIdline Glioma paTients(REMIT) | not yet recruiting | N/A | 59 | Rigshospitalet, DenmarkOTHER | 0 | Oct 23, 2023 | clinicaltrials |
| NCT03841435 | Hypofractionated Radiotherapy for Recurrent DIPG | completed | N/A | 5 | University of CincinnatiOTHER | 1 | Sep 13, 2023 | clinicaltrials |
| NCT06017063 | Coaching for Coping in Glioblastoma Patients and Caregivers and Its Association With Compliance to TTFields(COCOON) | not yet recruiting | N/A | 275 | University Hospital TuebingenOTHER | 0 | Aug 30, 2023 | clinicaltrials |
| NCT05969691 | Radiomics-Based Visualization and Quantitative Validation of IDH1 Heterogeneity in Gliomas | active not recruiting | N/A | 18 | Mingge LLCINDUSTRY | 1 | Aug 8, 2023 | clinicaltrials |
| NCT05896449 | Predictive Values of Preoperative [68Ga]Ga-PSMA-11 PET/CT in Patients With Suspected Brain Tumours of Glial Origin | completed | N/A | 49 | Medical University of WarsawOTHER | 1 | Jun 9, 2023 | clinicaltrials |
| NCT03915912 | Mindfulness Meditation in Glioma Patients | completed | N/A | 17 | Duke UniversityOTHER | 1 | Jun 7, 2023 | clinicaltrials |
| NCT03411408 | Accelerated Hypofractionated Intensity - Modulated Radiotherapy After Hyperbaric Oxygenation for Recurrent High Grade Glioma.(HBO-RT) | unknown | N/A | 24 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSOTHER | 1 | May 30, 2023 | clinicaltrials |
| NCT03055208 | Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma(Gamma-GBM) | suspended | N/A | 50 | Universitätsmedizin MannheimOTHER | 1 | May 11, 2023 | clinicaltrials |
| NCT05410301 | Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma | withdrawn | N/A | 0 | Varun Monga, MDOTHER | 1 | Apr 21, 2023 | clinicaltrials |
| NCT05811793 | Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma. | unknown | N/A | 36 | Second Affiliated Hospital of Nanchang UniversityOTHER | 0 | Apr 13, 2023 | clinicaltrials |
| NCT05793021 | FKBP51s: a New Molecular Biomarker for Glioblastoma? Pre- and Post-operative Blood Levels Evaluation of FKBP51s Protein and Correlation With MRI Phenotype | unknown | N/A | 70 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 31, 2023 | clinicaltrials |
| NCT04630379 | Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers | completed | N/A | 16 | Mayo ClinicOTHER | 1 | Mar 20, 2023 | clinicaltrials |
| NCT05772741 | Grafts of GSCs Into Brain Organoids for Testing Anti-invasion Drugs(2253) | unknown | N/A | 160 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 16, 2023 | clinicaltrials |
| NCT03956706 | Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas | withdrawn | N/A | 0 | Northwell HealthOTHER | 1 | Mar 15, 2023 | clinicaltrials |
| NCT02296580 | A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) | completed | N/A | 37 | Nativis, Inc.INDUSTRY | 2 | Feb 2, 2023 | clinicaltrials |
| NCT03276286 | Nativis Voyager for Newly Diagnosed GBM(NAT109) | completed | N/A | 37 | Nativis, Inc.INDUSTRY | 1 | Feb 2, 2023 | clinicaltrials |
| NCT02274987 | Molecular Profiling for Individualized Treatment Plan for DIPG | completed | N/A | 38 | University of California, San FranciscoOTHER | 1 | Nov 4, 2022 | clinicaltrials |
| NCT01954576 | NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme | terminated | N/A | 21 | University of FloridaOTHER | 1 | Oct 31, 2022 | clinicaltrials |
| NCT05557240 | Neoantigens Phase I Trial in Newly Diagnosed Glioblastoma Patients | unknown | N/A | 10 | Shanghai 10th People's HospitalOTHER | 1 | Oct 12, 2022 | clinicaltrials |
| NCT05539339 | Personalized Trial in ctDNA-level-relapse Glioblastoma | unknown | N/A | 20 | Henan Provincial People's HospitalOTHER | 1 | Sep 27, 2022 | clinicaltrials |
| NCT05512195 | Safety and Efficacy of a New Approach to Delineating Clinical Target Volume of Glioblastoma(GBM) | unknown | N/A | 70 | Zhongnan HospitalOTHER | 0 | Aug 23, 2022 | clinicaltrials |
| NCT04596930 | MR-guided LITT Therapy in Patients With Primary Irresectable Glioblastoma(EMITT) | completed | N/A | 15 | Radboud University Medical CenterOTHER | 1 | Aug 9, 2022 | clinicaltrials |
| NCT05099068 | Profiling Program of Cancer Patients With Sequential Tumor and Liquid Biopsies (PLANET)(PLANET) | unknown | N/A | 500 | Centre Leon BerardOTHER | 1 | Jul 5, 2022 | clinicaltrials |
| NCT05263466 | Establishing Radiolabelled PSMA as a Target for Glioma Treatment | not yet recruiting | N/A | 30 | King's College Hospital NHS TrustOTHER | 1 | Jun 10, 2022 | clinicaltrials |
| NCT00103038 | Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases | completed | N/A | 155 | OHSU Knight Cancer InstituteOTHER | 1 | Jun 9, 2022 | clinicaltrials |
| NCT05399524 | Functional and Ultrasound Guided Resection of Glioblastoma(FUTURE-GB) | unknown | N/A | 357 | University of OxfordOTHER | 1 | Jun 1, 2022 | clinicaltrials |
| NCT03390569 | Exercise in Patients With Glioblastoma | completed | N/A | 54 | University Health Network, TorontoOTHER | 1 | Apr 14, 2022 | clinicaltrials |
| NCT02359097 | Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma | completed | N/A | 29 | OHSU Knight Cancer InstituteOTHER | 1 | Mar 17, 2022 | clinicaltrials |
| NCT04516733 | Precoce Medical Care by the Mobil Support for Patients With Glioblastoma(GLIOSUPPORT) | completed | N/A | 35 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Mar 14, 2022 | clinicaltrials |
| NCT01925573 | Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344) | terminated | N/A | 7 | University of Maryland, BaltimoreOTHER | 1 | Feb 3, 2022 | clinicaltrials |
| NCT02379572 | Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas | completed | N/A | 315 | University Hospital TuebingenOTHER | 1 | Oct 22, 2021 | clinicaltrials |
| NCT02076152 | FMISO PET Study of Glioblastoma | completed | N/A | 11 | Massachusetts General HospitalOTHER | 1 | Jul 30, 2021 | clinicaltrials |
| NCT03787056 | Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients(ONCOPRO) | recruiting | N/A | 410 | Hospices Civils de LyonOTHER | 1 | Jul 16, 2021 | clinicaltrials |
| NCT04856852 | Iodine-125 Brachytherapy Together With Chemotherapy in Patients With Newly Diagnosed Glioblastoma(IBCNG) | unknown | N/A | 84 | The Affiliated Hospital of Qingdao UniversityOTHER | 0 | Jun 29, 2021 | clinicaltrials |
| NCT01754350 | Calorie-restricted, Ketogenic Diet and Transient Fasting During Reirradiation for Patients With Recurrent Glioblastoma(ERGO2) | completed | N/A | 50 | Johann Wolfgang Goethe University HospitalOTHER | 1 | Jun 2, 2021 | clinicaltrials |
| NCT04902586 | Effect of Radiotherapy Concurrent of TTFields in Patients With Glioblastoma(ECTG001) | unknown | N/A | 30 | Zhongnan HospitalOTHER | 1 | May 26, 2021 | clinicaltrials |
| NCT04790097 | FET-PET Directed Simultaneous In-field Boost for Primary GBM(dualFETboost) | completed | N/A | 17 | Prof. Franciszek Lukaszczyk Memorial Oncology CenterOTHER | 1 | May 6, 2021 | clinicaltrials |
Data updated 23 days agoSource updated May 9, 2024source: clinicaltrials